Hahn: User fee-related reviews on schedule amid COVID-19

The US Food and Drug Administration’s (FDA) user fee funded reviews of drugs, biologics and medical devices are progressing according to schedule despite the disruption caused by the coronavirus disease (COVID-19) pandemic, FDA Commissioner Stephen Hahn said on Thursday.